The Gamma4 System includes length-dependent RoC long nails, chamfered distal tip, and shortened proximal body. Credit: Stryker.

Medical technology company Stryker has introduced the new Gamma4 System for the treatment of stable and unstable fractures.

With the newest Gamma System, surgeons will get access to the company’s next-generation intramedullary nailing system, which has also been designed to stabilise bones.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Gamma4 System is also indicated to correct bone deformities in the intracapsular, subtrochanteric, trochanteric, and shaft regions of the femur, which include osteoporotic and osteopenic bone.

It features a precision pin, which reduces the potential for skiving by 66% compared to a standard ∅3.2 k-wire.

The SOMA-designed nail of the system includes length-dependent RoC long nails, chamfered distal tip, and shortened proximal body with a pre-inserted and cannulated set screw.

Stryker stated that the new Gamma4 System also features an integrated platform.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Stryker Trauma business vice-president and general manager Eric Tamweber said: “Since 2004, the Gamma3 System has been the proven workhorse of our Trauma business.

“But we aren’t proven because we have a legacy; we have a legacy because we are proven.

“That’s why we’re so excited to introduce Gamma4 – an enhanced, modern product that is designed to fulfil our customers’ hip fracture needs.”

In September last year, Stryker introduced the Citrelock Tendon Fixation Device System.

The system was designed to enable fixation without causing damage to the tendon during placement.

Citrelock Tendon Fixation Device System offers a controlled and homogeneous resorption process while preventing bulk degradation and chronic inflammation

It also offers surgeons a strength similar to cortical bone and a modulus in line with cancellous bone.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact